Turning the Tide for Horseshoe Crabs:
New Hope for an Ancient Species

New Study Proves Synthetic Can Replace Horseshoe Crab Blood in Biomedical Testing

On May 10, 2018 in Cape May, New Jersey, Revive & Restore joined with the state’s First Lady Tammy Murphy, the New Jersey Audubon Society, and representatives of Eli Lilly to announce new research findings that dispel the barriers to adopting a synthetic alternative to horseshoe crab blood for biomedical testing.

In 1997,  Jeak Ling DING (pictured above) and Bow Ho (her husband and research partner) invented Recombinant Factor C (rFC), the synthetic alternative to the horseshoe crab-derived Limulus amebocyte lysate (LAL), a test used to detect bacterial contamination in injectable medications.

“Revive & Restore’s focus on this issue is exactly what was needed to galvanize pharma to ‘do the right thing’ and embrace 21st-century technology. We hope this will not be too late for the endangered horseshoe crabs.”

—Jeak Link DING, Co-inventor of rFC